Tern Therapeutics

Tern Therapeutics is a biotechnology company dedicated to developing one-time gene therapy treatments for rare diseases. They are driven by a commitment to delivering transformative treatments to those living with rare diseases around the world. Their mission is inspired by the strength and determination of the Arctic tern, a bird known for its long migrations. Their lead candidate, TTX-381, is currently in clinical testing for the treatment of ocular manifestations of CLN2 disease, a form of Batten disease.

Tern Therapeutics prioritizes patient needs and works closely with patient communities. Their values of urgency, innovation, integrity, empathy, and determination guide their work. They are committed to relentless scientific, regulatory, and commercial innovation to deliver their cutting-edge treatments efficiently and effectively. They are also committed to transparency and collaboration, ensuring that patients and their families are informed and involved throughout the development process.

Tern Therapeutics is a company dedicated to developing innovative, one-time genetic treatments for rare diseases. They are committed to delivering transformative therapies to patients worldwide with a sense of urgency and empathy. They believe that treatments for rare diseases are just as valuable as those for more common illnesses, and they are determined to improve the lives of those living with these conditions. They are currently developing TTX-381, a gene therapy treatment for the ocular manifestations of CLN2 disease, which is a rare form of Batten disease.

Tern Therapeutics cultivates a culture rooted in empathy and urgency, driven by a profound commitment to improving the lives of children with rare diseases. The company prioritizes collaboration with patient communities, demonstrating its dedication to integrity and innovation in the relentless pursuit of transformative, one-time genetic treatments. Its values of empathy, urgency, integrity, innovation, and determination are embodied in its name, inspired by the resilient Arctic tern, signifying the company's unwavering resolve to reach the ends of the earth to fulfill its mission.

Tern Therapeutics emphasizes diversity, equity, and inclusion by placing patients and their families at the heart of their work, fostering a culture of empathy, integrity, and urgency. They are dedicated to working in partnership with patient communities and are committed to delivering treatments to those living around the world with rare diseases.